189 related articles for article (PubMed ID: 34319007)
1. RNA editing affects cis-regulatory elements and predicts adverse cancer survival.
Wu YM; Guo Y; Yu H; Guo T
Cancer Med; 2021 Sep; 10(17):6114-6127. PubMed ID: 34319007
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
3. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
4. RNA editing and drug discovery for cancer therapy.
Huang WH; Tseng CN; Tang JY; Yang CH; Liang SS; Chang HW
ScientificWorldJournal; 2013; 2013():804505. PubMed ID: 23737728
[TBL] [Abstract][Full Text] [Related]
5. Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
Maemura K; Watanabe K; Ando T; Hiyama N; Sakatani T; Amano Y; Kage H; Nakajima J; Yatomi Y; Nagase T; Takai D
Cancer Sci; 2018 Oct; 109(10):3326-3335. PubMed ID: 30022565
[TBL] [Abstract][Full Text] [Related]
6. Uncovering
Feng C; Cao X; Du Y; Chen Y; Xin K; Zou J; Jin Q; Xu JR; Liu H
mBio; 2022 Oct; 13(5):e0187222. PubMed ID: 36102513
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of RNA and DNA editing in cancer.
Avesson L; Barry G
Biochim Biophys Acta; 2014 Apr; 1845(2):308-16. PubMed ID: 24607277
[TBL] [Abstract][Full Text] [Related]
8. "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
An O; Song Y; Ke X; So JB; Sundar R; Yang H; Rha SY; Lee MH; Tay ST; Ong X; Tan ALK; Ng MCH; Tantoso E; Chen L; Tan P; Yong WP;
Cancer Res; 2021 May; 81(10):2788-2798. PubMed ID: 33558338
[TBL] [Abstract][Full Text] [Related]
9. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
[TBL] [Abstract][Full Text] [Related]
10. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
Wang Y; Liang H
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
[TBL] [Abstract][Full Text] [Related]
11. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Ouyang D; Li R; Li Y; Zhu X
Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
[TBL] [Abstract][Full Text] [Related]
13. RNA Editing in Glioma as a Sexually Dimorphic Prognostic Factor That Affects mRNA Abundance in Fatty Acid Metabolism and Inflammation Pathways.
Lin SH; Chen SC
Cells; 2022 Apr; 11(7):. PubMed ID: 35406793
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RNA editing by RNA-binding proteins in human cells.
Quinones-Valdez G; Tran SS; Jun HI; Bahn JH; Yang EW; Zhan L; Brümmer A; Wei X; Van Nostrand EL; Pratt GA; Yeo GW; Graveley BR; Xiao X
Commun Biol; 2019; 2():19. PubMed ID: 30652130
[TBL] [Abstract][Full Text] [Related]
15. A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma.
Liu L; Liu J; Deng X; Tu L; Zhao Z; Xie C; Yang L
BMC Cancer; 2022 Jun; 22(1):715. PubMed ID: 35768804
[TBL] [Abstract][Full Text] [Related]
16. RNA editing in cancer impacts mRNA abundance in immune response pathways.
Chan TW; Fu T; Bahn JH; Jun HI; Lee JH; Quinones-Valdez G; Cheng C; Xiao X
Genome Biol; 2020 Oct; 21(1):268. PubMed ID: 33106178
[TBL] [Abstract][Full Text] [Related]
17. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract][Full Text] [Related]
18. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
19. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Investigation and Functional Analysis of
Wang Z; Feng X; Tang Z; Li SC
Genes (Basel); 2019 Apr; 10(5):. PubMed ID: 31052161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
